Annovis Bio, Inc.
NYSEANVS utilization hits 90.79%, near its 52-week peak of 100%, as short interest climbs 72% over one month to 18.1% of float.
Snapshot as of 8 May 2026
No long-form analysis yet for ANVS. Pulse alerts and the live data picture are available on ORTEX.
Open ANVS on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ANVS — free to start on ORTEX.
Sign up for free →Open ANVS on ORTEX